GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Precipio Inc (FRA:TGK) » Definitions » Cyclically Adjusted PB Ratio

Precipio (FRA:TGK) Cyclically Adjusted PB Ratio : (As of Jun. 09, 2024)


View and export this data going back to . Start your Free Trial

What is Precipio Cyclically Adjusted PB Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PB Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Precipio Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Precipio's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precipio Cyclically Adjusted PB Ratio Chart

Precipio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.01

Precipio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.01 0.01

Competitive Comparison of Precipio's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Precipio's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Precipio's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Precipio's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Precipio's Cyclically Adjusted PB Ratio falls into.



Precipio Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Precipio's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Precipio's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=8.512/131.7762*131.7762
=8.512

Current CPI (Mar. 2024) = 131.7762.

Precipio Quarterly Data

Book Value per Share CPI Adj_Book
201406 9,254.878 100.560 12,127.871
201409 9,646.341 100.428 12,657.433
201412 5,868.889 99.070 7,806.422
201503 7,003.788 99.621 9,264.429
201506 7,078.102 100.684 9,263.898
201509 3,838.065 100.392 5,037.933
201512 -7,616.774 99.792 -10,057.976
201603 -6,026.087 100.470 -7,903.769
201606 -5,642.023 101.688 -7,311.419
201609 -5,926.493 101.861 -7,667.024
201612 -2,085.714 101.863 -2,698.215
201703 -6,477.517 102.862 -8,298.311
201706 822.987 103.349 1,049.357
201709 543.696 104.136 688.009
201712 323.801 104.011 410.238
201803 165.863 105.290 207.588
201806 138.856 106.317 172.107
201809 99.343 106.507 122.913
201812 46.824 105.998 58.211
201903 40.427 107.251 49.672
201906 42.016 108.070 51.233
201909 38.921 108.329 47.345
201912 30.096 108.420 36.579
202003 21.487 108.902 26.000
202006 15.322 108.767 18.563
202009 14.085 109.815 16.902
202012 13.221 109.897 15.853
202103 13.462 111.754 15.874
202106 19.904 114.631 22.881
202109 19.374 115.734 22.059
202112 19.146 117.630 21.449
202203 17.758 121.301 19.292
202206 17.090 125.017 18.014
202209 16.107 125.227 16.949
202212 13.487 125.222 14.193
202303 11.321 127.348 11.715
202306 9.394 128.729 9.616
202309 8.780 129.860 8.910
202312 9.584 129.419 9.759
202403 8.512 131.776 8.512

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Precipio  (FRA:TGK) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Precipio Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Precipio's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Precipio (FRA:TGK) Business Description

Traded in Other Exchanges
Address
4 Science Park, New Haven, CT, USA, 06511
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings.

Precipio (FRA:TGK) Headlines

No Headlines